LIGAND PHARMACEUTICALS INCORPORATED
Net Cash Flow Breakdown
Total Cash from Operations: $156.0M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Working Capital | $5.4M | 3.5% |
| Other | $2.0M | 1.3% |
| Net Cash Flow | $148.6M | 95.2% |
Net Cash Flow Breakdown
Total Cash from Operations: $156.0M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Working Capital | $5.4M | 3.5% |
| Other | $2.0M | 1.3% |
| Net Cash Flow | $148.6M | 95.2% |